Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-12-13
1986-01-07
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
045634653
ABSTRACT:
Migraine is treated with a tropyl benzoate derivative of the following general formula: ##STR1## wherein: R.sub.1 represents C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen;
REFERENCES:
patent: 3170927 (1965-02-01), Nador et al.
Fozard, Adv. in Neurology, 33--295-307 (1982).
Fozard et al., European Journal of Pharmacology, 59 195-209 (1979).
Chem. Abst. 28-5596.sup.9 (1934), 30-1871.sup.6 (1934), 34-7009.sup.7 (1940), 59-5665g(1963), 67-53953 & 78-119197, 39-1926.sup.8 (1945), 63-16951G.
Chem. Abst. 85 (1976)--87108t.
Fozard John R.
Gittos Maurice W.
Friedman Stanley J.
McDonald Raymond A.
Merrell Dow Pharmaceuticals Inc.
Stein William J.
LandOfFree
Treatment of migraine with substituted tropyl benzoate derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of migraine with substituted tropyl benzoate derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of migraine with substituted tropyl benzoate derivativ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-111969